Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q15493
UPID:
RGN_HUMAN
Alternative names:
Gluconolactonase; Senescence marker protein 30
Alternative UPACC:
Q15493; A4FTW1; A8K271; Q53FC9; Q5JRR5
Background:
Regucalcin, also known as Senescence marker protein 30, plays a pivotal role in calcium signaling and homeostasis. It exhibits gluconolactonase activity, influencing sugar lactone hydrolysis, and modulates Ca(2+)-dependent processes. Its ability to bind calcium and hydrolyze compounds like diisopropyl phosphorofluoridate and phenylacetate highlights its biochemical versatility.
Therapeutic significance:
Understanding the role of Regucalcin could open doors to potential therapeutic strategies. Its involvement in calcium signaling and homeostasis positions it as a key player in cellular health and disease prevention.